DEVELOPMENT, SUPPLY AND COMMERCIALIZATION AGREEMENTDevelopment, Supply and Commercialization Agreement • May 19th, 2020 • BIO-TECHNE Corp • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 19th, 2020 Company Industry JurisdictionThis Development, Supply and Commercialization Agreement (this “Agreement”), effective as of May 19, 2020 (the “Effective Date”), is by and between Kantaro Biosciences LLC, a Delaware limited liability company with a principal business address of 1460 Broadway, New York, NY 10036 (“Sponsor”) and Bio-Techne Corporation, a Minnesota corporation having a principal business address at 614 McKinley Place NE, Minneapolis, MN 55413 (“Bio-Techne”). Capitalized terms used and not defined elsewhere in this Agreement have the meanings set forth in Section 1 of this Agreement.